Screener
Cogent Biosciences, Inc. COGT Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342393
FAQ
- What is Cogent Biosciences, Inc.'s net income?
- Cogent Biosciences, Inc. (COGT) reported net income of -$96.41M in Q2 2026.
- How has Cogent Biosciences, Inc.'s net income changed year-over-year?
- Cogent Biosciences, Inc.'s net income decreased by 31.1% year-over-year, from -$73.53M to -$96.41M.
- What is the long-term trend for Cogent Biosciences, Inc.'s net income?
- Over 4 years (2021 to 2025), Cogent Biosciences, Inc.'s net income has grown at a 46.1% compound annual growth rate (CAGR), from -$72.27M to -$328.94M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Cogent Biosciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude